China Biotech & Licensing 1 article

China Biotech & Licensing examines China's biotechnology sector with particular attention to therapeutic innovation and the cross-border movement of drug and platform rights. China-origin assets, domestic clinical development, company formation, partnerships and out-licensing are evaluated for how they enter global pipelines and deal networks. Broader Asia-Pacific coverage belongs elsewhere when China is not the dominant frame; here licensing is a defining bridge between Chinese biotechnology and international development.